, Volume 170, Issue 4, pp 358–367 | Cite as

Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790

  • Marie L. WoolleyEmail author
  • Charles A. Marsden
  • Andrew J. Sleight
  • Kevin C. F. Fone
Original Investigation



Accumulating evidence suggests a potential role for the 5-HT6 receptor in cognitive function and the potential use of 5-HT6 receptor antagonists in the treatment of learning and memory disorders.


The aim of the current study was to investigate the effect of the selective 5-HT6 receptor antagonist, Ro 04-6790, on both the performance of normal adult rats and restoration of a pharmacological disruption of memory function produced by the non-selective muscarinic receptor antagonist, scopolamine, or the dopamine D2 receptor antagonist, raclopride, in a rodent model of recognition memory.


Passive, perceptually based, recognition memory was assessed using a novel object discrimination task. Following habituation to an arena, rats were presented with two identical objects during trial 1 (T1) and a novel and familiar object during trial 2 (T2). The time spent exploring the two objects in each trial was measured and novel object discrimination assessed in T2.


In the absence of drug all rats spent an equal time exploring the two identical objects in T1 but more time exploring the novel object in T2. Scopolamine (but not N-methylscopolamine) and raclopride both produced a dose-dependent reduction in novel object discrimination whilst the 5-HT6 receptor antagonist, Ro 04-6790, had no effect on discrimination when given alone but completely reversed the scopolamine- but not the raclopride-induced deficit.


This study demonstrates that acute administration of Ro 04-6790 reverses a cholinergic but not a dopaminergic deficit in a rodent model of recognition memory and provides further support for a role of the 5-HT6 receptor in the regulation of cognitive function.


Memory Rats Ro 04-6790 5-HT6 receptor antagonists 



M.L.W. was an MRC case student supported by F. Hoffman-La Roche, who provided Ro 04-6790.


  1. Aggleton JP, Keen S, Warburton EC, Bussey TJ (1997) Extensive cytotoxic lesions involving both the rhinal corticies and are TE impair recognition but spare alternation in the rat. Brain Res Bull 43:279–287Google Scholar
  2. Ainge JA, Heron-Maxwell C, Wright PG, de Hoz L, Wood ER (2002) Comparison of complete and partial lesions in rats on spontaneous object recognition and spatial water maze performance. Soc Neurosci Abstr 585.5Google Scholar
  3. Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–417PubMedGoogle Scholar
  4. Bentley JC, Sleight AJ, Marsden CA, Fone KCF (1997) 5-HT6 antisense oligonucleotide ICV affects rat performance in the water maze and feeding. J Psychopharmacol 11:A64Google Scholar
  5. Bentley JC, Bourson A, Boess FG, Fone KCF, Marsden CA, Petit N, Sleight AJ (1999a) Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist Ro 04-6790:in rats. Br J Pharmacol 126:1537–1542PubMedGoogle Scholar
  6. Bentley JC, Marsden CA, Sleight AJ, Fone KCF (1999b) Effect of the 5-HT6 antagonist, Ro 04-6790 on food consumption in rats trained to a fixed feeding regime. Br J Pharmacol 126:66PGoogle Scholar
  7. Bös M, Sleight AJ, Godel T, Martin JR, Reimer C, Stadler H (2001) 5-HT6 receptor antagonists: lead optimisation and biological evaluation of n-aryl and -heteroaryl 4-amino-benzene sulfonamides. Eur J Med Chem 36:165–178CrossRefPubMedGoogle Scholar
  8. Bourson A, Borroni E, Austin RH, Monsma FJ Jr, Sleight AJ (1995) Determination of the role of the 5-HT6 receptor in the rat brain: a study using antisense oligonucleotides. J Pharmacol Exp Ther 274:173–180PubMedGoogle Scholar
  9. Bourson A, Boess FG, Bos M, Sleight AJ (1998) Involvement of 5-HT6 receptors in nigro-striatal function in rodents. Br J Pharmacol 125:1562–1566PubMedGoogle Scholar
  10. Bromidge SM, Brown AM, Clarke SE, Dodgson K, Gager T, Grassam HL, Jeffrey PM, Joiner GF, King FD, Middlemiss DN, Moss SF, Newman H, Riley G, Routledge C, Wyman P (1999) 5-Chloro-N-(methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophene-sulfonamide (SB-271046): a potent, selective and orally bioavailable 5-HT6 receptor antagonist. J Med Chem 42:202–205Google Scholar
  11. Clark RE, Zola SM, Squire LR (2000) Impaired recognition memory in rats after damage to the hippocampus. J Neurosci 20:8853–8860PubMedGoogle Scholar
  12. Consolo S, Baldi G, Giorgi S, Nannini L (1996) The cerebral cortex and parafasicular thalamic nucleus facilitate in vivo acetylcholine release in the rat striatum through distinct glutamate receptor subtypes. Eur J Neurosci 8:2702–2710PubMedGoogle Scholar
  13. Dawson LA, Nguyen HQ, Li P (2000) In vivo effects of the 5-HT6 antagonist, SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate. Br J Pharmacol 130:23–26PubMedGoogle Scholar
  14. Dawson LA, Nguyen HQ, Li P (2001) The 5-HT6 receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology 25:662–668CrossRefPubMedGoogle Scholar
  15. Didriksen M (1995) Effects of antipsychotics on cognitive behaviour in rats using the delayed non-match to position paradigm. Eur J Pharmacol 281:241–250PubMedGoogle Scholar
  16. Diez-Ariza M, Ramirez MJ, Lasheras B, Del Rio J (1998) Differential interaction between 5-HT3 receptors and GABAergic neurons inhibiting acetylcholine release in rat entorhinal cortex slices. Brain Res 801:228–232CrossRefPubMedGoogle Scholar
  17. Dunnett SB (1985) Comparative effects of cholinergic drugs and lesions of the nucleus basalis or fimbria-fornix on delayed matching in rats. Psychopharmacology 87:357–363Google Scholar
  18. Ennaceur A (1998) Effects of lesions of the substantia innominata ventra pallidum, globus pallidus and medial septum on rat's performance in object-recognition and radial-maze tasks: physostigmine and amphetamine treatments. Pharmacol Res 38:251–263PubMedGoogle Scholar
  19. Ennaceur A, Aggleton JP (1994) Spontaneous recognition of object configurations in rats—effects of fornix lesions. Exp Brain Res 100:85–92PubMedGoogle Scholar
  20. Ennacuer A, Delacour J (1988) A new one-trial test for neurobiological studies of memory in rats. I: Behavioural data. Behav Brain Res 31:47–59PubMedGoogle Scholar
  21. Ennaceur A, Meliani K (1992) Effects of physostigmine and scopolamine on rats' performances in object-recognition and radial-maze tests. Psychopharmacology 109:321–330PubMedGoogle Scholar
  22. Ennaceur A, Neave N, Aggleton JP (1996) Neurotoxic lesions of the perirhinal cortex do not mimic the behavioural effects of fornix transection in the rat. Behav Brain Res 80:9–25PubMedGoogle Scholar
  23. Ennaceur A, Neave N, Aggleton JP (1997) Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix. Exp Brain Res 113:509–519PubMedGoogle Scholar
  24. Feldman RS, Meyer JS, Quenzer LF (1997) Catecholamines: In: Principles of neuropsychopharmacology. Sinauer, Sunderland, Mass., pp 277–344Google Scholar
  25. Freund TF (1992) GABAergic septal and serotonergic median raphé afferents preferentially innervate inhibitory interneurones in the hippocampus and dentate gyrus. Epilepsy Res Suppl 7:79–91PubMedGoogle Scholar
  26. Freund TF, Gulyas AI, Acsady L, Gorcs T, Toth K (1990) Serotonergic control of the hippocampus via local inhibitory interneurones. Proc Natl Acad Sci USA 87:8501–8505PubMedGoogle Scholar
  27. Gérard C, Martres MP, Lefevre K, Miquel M-C, Verge D, Lanfumey L, Doucet E, Hamon M, El Mestikaway S (1997) Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system. Brain Res 746:207–219CrossRefPubMedGoogle Scholar
  28. Hamon MH, Doucet E, Lefévre K, Miquel M-C, Lanfumey L, Insausti R, Frechill D, Del Rio J, Vergé D (1999) Antibodies and antisense oligonucleotide for probing the distribution and putative functions of central 5-HT6 receptors. Neuropsychopharmacology 21:68S–76SCrossRefPubMedGoogle Scholar
  29. Harder JA, Kelly ME, Cheng CHK, Costall B (1996) Combined pCPA and muscarinic antagonist treatment produced a deficit in rat water maze acquisition, Pharmacol Biochem Behav 55:61–65Google Scholar
  30. Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533–554CrossRefPubMedGoogle Scholar
  31. Issac M, Slassi A, Xin T, Maclean N, Wilson J, McCallum K, Wang H, Demchyshyn L (2000) 6-Bicyclopiperazinyl-1-arylsulfonylindoes and 6-Bicyclopiperidinyl-1-arylsufony-lindoles derivatives as novel, potent, and selective 5-HT6 receptor antagonists. Bioorg Med Chem Lett 10:1719–1721CrossRefPubMedGoogle Scholar
  32. Jackson DM, Westlind-Danielsson A (1994) Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmacol Ther 64:291–370PubMedGoogle Scholar
  33. Kohen R, Metcalf MA, Khan N, Druck T, Huebner K, Lachowicz JE, Meltzer HY, Sibley DR, Roth BL, Hamblin MW (1996) Cloning, characterisation and chromosomal location of a human 5-HT6 serotonin receptor. J Neurochem 66:47–56PubMedGoogle Scholar
  34. Lee M, Ragisetty JB, Dukat M, Slassi A, Maclean N, Lee DKH, Glennon RA (2000) 5-HT6 serotonin receptor bindings affinities of N1-benzenesulfonyl and related tryptamines. Med Chem Res 10:230–242Google Scholar
  35. Meneses A (2001) Effects of the 5-HT6 receptor antagonist Ro 04-6790 on learning consolidation. Behav Brain Res 118:107–110CrossRefPubMedGoogle Scholar
  36. Monsma FJ Jr, Shen Y, Ward RP, Hamblin MW, Sibley DR (1993) Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol 43:320–327PubMedGoogle Scholar
  37. Mostafa R, Ennaceur A (2001) Fornix lesions impair both spatial and non-spatial memory in rats: space vs. featureless objects. Eur J Neurosci 12:252SGoogle Scholar
  38. Mumby DG, Gaskin S, Glenn MJ, Schramek TE, Lehmann H (2002) Hippocampal damage and exploratory preferences in rats: memory for objects, places, and contexts. Learn Mem 9:49–57CrossRefPubMedGoogle Scholar
  39. Ni J-W, Nakato K, Morita T, Okada, M, Yamaguchi T (2001) Acetylcholinesterase inhibitors improve aged rats' memory performance in object recognition. Soc Neurosci Abstr 27:P212Google Scholar
  40. Noyce JN, Kaeger C, Ryoo H, Goldsmith S (1993) Dopamine D2 receptors in the hippocampus and amygdala in Alzheimer's disease. Neurosci Lett 154:171–174CrossRefPubMedGoogle Scholar
  41. Otano A, Frechilla D, Cobreros A, Cruz-Orive LM, Insausti A, Insausti R, Hamon M, Rio JD (1999) Anxiogenic-like effects and reduced stereological counting of immunolabelled 5-hydroxytryptamine6 receptors in rat nucleus accumbens by antisense oligonucleotides. Neuroscience 92:1001–1009CrossRefPubMedGoogle Scholar
  42. Pontecorvo MJ, Clissold DB, White MF, Ferkany JW (1991) N-Methyl-aspartate antagonists and working memory performance: comparison with effects of scopolamine, propranolol, diazepam, and phenylisopropyladenosine. Behav Neurosci 105:521–535PubMedGoogle Scholar
  43. Pouzet B, Didriksen M, Arnt J (2002) Effects of 5-HT6 receptor antagonists, SB-271046:in animal models for schizophrenia. Pharmacol Biochem Behav 71:635–643CrossRefPubMedGoogle Scholar
  44. Ramirez MJ, Cenarruzabeitia E, Lasheras B, Del Rio J (1996) Involvement of GABA systems in acetylcholine release induced by 5-HT3 receptor blockade in slices from rat entorhinal cortex. Brain Res 712:274–280CrossRefPubMedGoogle Scholar
  45. Roberts JC, Reavill C, East SZ, Harrison PJ, Patel S, Routledge C, Leslie RA (2002) The distribution of 5-HT6 receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT6 receptor antagonist [125I]SB-258585. Brain Res 934:49–57CrossRefPubMedGoogle Scholar
  46. Rogers DC, Hagan JJ (2001) 5-HT6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacology 158:114–119CrossRefPubMedGoogle Scholar
  47. Rogers DC, Robinson TL, Quilter CA, Hunter AJ, Routledge C, Hagan JJ (1999) Cognitive enhancement effects of the selective antagonist SB-271046. Br J Pharmacol 121:22PGoogle Scholar
  48. Rogers DC, Hatcher PD, Hagan JJ (2000) The selective 5-HT6 receptor antagonist, SB-271046-A enhances performance of maze tasks in the rat. Soc Neurosci Abstr 26:680Google Scholar
  49. Roth BL, Craigo SC, Choudhary MS, Ulver A, Monsma FJ Jr, Shen Y, Meltzer HY, Sibley DR (1994) Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 263:1403–1410Google Scholar
  50. Routledge C, Bromidge SM, Moss SF, Price GW, Hirst W, Newman H, Riley G, Gager T, Stean T, Upton N, Clarke SE, Brown AM, Middlemiss DN (2000) Characterization of SB-271046: a potent, selective and orally active 5-HT6 receptor antagonist. Br J Pharmacol 130:1606–1612PubMedGoogle Scholar
  51. Routledge C, Price GW, Bromidge SM, Moss SF, Newman H, Riley G, Gager T, Brown A M, Lighowler S, Middlemiss DN (1999) Characterization of SB-271046: a potent and selective 5-HT6 receptor antagonist. Br J Pharmacol 121:21PGoogle Scholar
  52. Ruat M, Traiffort E, Arrang J.M, Tardivel-Lacombe J, Diaz J, Leurs R, Schwartz JC (1993) A novel rat serotonin (5HT6) receptor; molecular cloning, localisation and stimulation of cAMP accumulation. Biochem Biophys Res Commun 193:268–276CrossRefPubMedGoogle Scholar
  53. Russell MGN, Baker RJ, Barden L, Beer MS, Bristow L, Broughton HB, Knowles M, McAllister G, Patel S, Castro JL (2001) N-Arylsulfonylindole derivatives as serotonin 5-HT6 receptor ligands. J Med Chem 44:3881–3895CrossRefPubMedGoogle Scholar
  54. Shirazi-Southall S, Rodriguez DE, Nomikos GG (2002) Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology 26:583–594Google Scholar
  55. Slassi A, Edwards L, O'Brien A, Xin T, Tehim A (2000) Preparation of 1-(arylsulfonyl)-3-(tetrahydropyridinyl)indoles as 5-HT6 receptor inhibitors. US Patent 6:133:287Google Scholar
  56. Sleight AJ, Boess FG, Bos M, Levet-Trafit B, Riemer C, Bourson A (1998) Characterisation of Ro 04-6790 and Ro 63–0563: potent and selective antagonists at human and rat 5HT6 receptors. Br J Pharmacol 124:556–562PubMedGoogle Scholar
  57. Sleight AJ, Consolo S, Martin JR, Boes M, Boess FG, Bentley JC, Bourson A (1999) 5-HT6 receptors: functional correlates and potential therapeutic indications. Behav Pharmacol 10:S86Google Scholar
  58. Steckler T, Drinkenburg WHIM, Sahgal A, Aggleton JP (1998) Recognition memory in rats II. Neuroanatomical substrates. Prog Neurobiol 54:313–332PubMedGoogle Scholar
  59. Stean TO, Hirst WD, Thomas DR, Price GW, Rogers D, Riley G, Bromidge SM, Serafinowska HT, Smith DR, Bartlett S, Deeks N, Duxon M, Upton N (2002) Pharmacological profile of SB-357134: a potent, selective, brain penetrant, and orally active 5-HT6 receptor antagonist. Pharmacol Biochem Behav 71:645–654CrossRefPubMedGoogle Scholar
  60. Tsai S-J, Shiu H-J, Wang Y-C, Hong, C-J (1999) Association study of serotonin-6 receptor variant (C267T) with schizophrenia and aggressive disorder. Neurosci Lett 271:135–137CrossRefPubMedGoogle Scholar
  61. Tsai Y, Dukat M, Slassi A, Maclean N, Demschyshyn L, Savage JE, Roth BL, Hufesein S, Lee M, Glennon RA (2000) N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists. Bioorg Med Chem Lett 10:2295–2299CrossRefPubMedGoogle Scholar
  62. Umegaki H, Munoz J, Meyer RC, Spangler EL, Yoshimura J, Ikari H, Iguchi A, Ingram DK (2001) Involvement of dopamine D2 receptors in complex maze learning and acetylcholine in ventral hippocampus of rats. Neuroscience 103:27–33CrossRefPubMedGoogle Scholar
  63. Vizi ES, Kiss JP (1998) Neurochemistry and pharmacology of the major hippocampal transmitter systems; synaptic and non-synaptic interactions. Hippocampus 8:566–607CrossRefPubMedGoogle Scholar
  64. Vogt IR, Shimron-Abarbanell D, Neidt H, Erdmann J, Cichon S, Schulze TG, Muller DJ, Maier W, Albus M, Borrmann-Hassenbach M, Knapp M, Reitschel M, Propping P, Nothen MM (2000) Investigation of the human serotonin 6 (5-HT6) receptor gene in bipolar affective disorder and schizophrenia. Am J Med Genet 96:217–221CrossRefPubMedGoogle Scholar
  65. Wan RQ, Pang K, Olton DS (1997) Nonhippocampal muscarinic receptors are required for nonspatial working memory. Pharmacol Biochem Behav 58:361–367CrossRefPubMedGoogle Scholar
  66. Ward RP, Dorsa DM (1996) Colocalization of serotonin receptor subtypes, 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptides in rat striatum. J Comp Neurol 370:405–414CrossRefPubMedGoogle Scholar
  67. Wiig KA, Bilkey DK (1995) Lesions of rat perirhinal cortex exacerbate the memory deficit observed following damage to the fimbria-fornix. Behav Neurosci 109:620–630CrossRefPubMedGoogle Scholar
  68. Wilkerson A, Levin ED (1999) Ventral hippocampal dopamine D1 and D2 systems and spatial working memory in rats. Neuroscience 89:743–749CrossRefPubMedGoogle Scholar
  69. Woods ER, Phillips AG (1991) Deficits on a one trial object recognition task by rats with hippocampal CA1 lesions produced by cerebral ischemia. Neurosci Res Commun 9:177–182Google Scholar
  70. Woolley ML, Marsden CA, Sleight AJ, Fone KCF (2000) Co-localisation of 5-HT6 receptors on GABAergic but not cholinergic neurones in the adult rat brain. Brain Res Bull :94Google Scholar
  71. Woolley ML, Marsden CA, Sleight AJ, Fone KCF (2001) A role for 5-HT6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacology 41:210–219CrossRefPubMedGoogle Scholar
  72. Yau JLW, Noble J, Widdowson J, Seckl JR (1997) Impact of adrenalectomy on 5HT6 and 5HT7 receptor gene expression in the rat hippocampus. Mol Brain Res 45:182–186CrossRefPubMedGoogle Scholar
  73. Yoshioka M, Matsumoto M, Togashi H, Mori K and Saito H (1998) Central distribution and function of 5HT6 receptor subtype in the rat brain. Life Sci 62:1473–1477CrossRefPubMedGoogle Scholar
  74. Yu W-YY, Tsai S-J, Lin C-H, Hsu C-P, Yang K-H, Hong C-J (1999) Serotonin-6 receptor variant (C267T) and clinical response to clozapine. Neuroreport 10:1231–1233PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Marie L. Woolley
    • 1
    • 3
    Email author
  • Charles A. Marsden
    • 1
  • Andrew J. Sleight
    • 2
  • Kevin C. F. Fone
    • 1
  1. 1.Institute of Neuroscience, School of Biomedical Science, Queen's Medical CentreUniversity of NottinghamNottinghamUK
  2. 2.PRBD-NF. Hoffmann La-RocheBaselSwitzerland
  3. 3.Bau 72/129, PRBD-NF. Hoffmann La-RocheBaselSwitzerland

Personalised recommendations